Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-26-227256
Filing Date
2026-05-15
Accepted
2026-05-15 17:25:44
Documents
13
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A rnxt-20251231.htm   iXBRL 10-K/A 1064318
2 EX-31.1 rnxt-ex31_1.htm EX-31.1 16033
3 EX-31.2 rnxt-ex31_2.htm EX-31.2 16162
4 EX-32.1 rnxt-ex32_1.htm EX-32.1 8761
5 EX-32.2 rnxt-ex32_2.htm EX-32.2 8816
  Complete submission text file 0001193125-26-227256.txt   3017844

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rnxt-20251231.xsd EX-101.SCH 1162613
17 EXTRACTED XBRL INSTANCE DOCUMENT rnxt-20251231_htm.xml XML 11655
Mailing Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040
Business Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

EIN.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40738 | Film No.: 26989897
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)